Financial News
Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)
All News about Bio-Rad Laboratories, Inc. Class A Common Stock



Via Benzinga
Topics
Product Recall







Bio-Rad Reports First-Quarter 2021 Financial Results
April 29, 2021
Via Business Wire



Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Via Benzinga
Exposures
Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.